ObvioHealth Is Ready For Decentralized Trials To Continue Growth Post-Pandemic
Executive Summary
ObvioHealth is redefining clinical trials with its remote approach to address poor-quality patient-reported data and high costs while simultaneously discovering new trial outcomes.
You may also be interested in...
ObvioHealth Is Building A New Digital Ecosystem To 'Revolutionize' Trials
Using artificial intelligence and strict data collection protocol, ObvioHealth hopes to digitize clinical trials with the assistance of medical devices and consumer technology.
Liquid Biopsy Revolutionizing Cancer Care, But Costs Continue To Inhibit Global Potential
Liquid biopsy represents potential advantages over traditional approaches to cancer surveillance, treatment selection and recurrence monitoring. But one size does not fit all, requiring tailored solutions for less developed markets.
Minute Insight: Indigo Diabetes Starts Human Trial Of Subcutaneous Glucose Monitor
The company has enrolled the first patient in the second human trial of its implantable metabolite monitoring system, which it expects could change the game for blood glucose measurement.